VSKR121. Distribution of Cervical Cancer Screening Results by Primary Screening Outcome and Age Group (from 2021). PxWeb

VSKR121. Distribution of Cervical Cancer Screening Results by Primary Screening Outcome and Age Group (from 2021)

Mark your selections and choose between table on screen and file format. Marking tips

For variables marked you need to select at least one value

Year

Total 4 Selected

Beginning of word

Result

Total 11 Selected

Beginning of word

Indicator

Total 2 Selected

Beginning of word

Age group

Total 11 Selected

Beginning of word

Number of selected data cells are:(maximum number allowed is 1 000 000)

Presentation on screen is limited to 1 000 rows and 50 columns

Number of selected cells exceeds the maximum allowed 1 000 000

Information

Official statistics: No
Latest update: 09.03.2026.
Unit: Number / proportion
Next update: 30.09.2026.
Creation date: 20.02.2026.
Source: The Centre for Disease Prevention and Control of Latvia
Matrix: VSKR121
Database: NHS Healthcare Payment Billing System “Management Information System”

Footnotes

: From June 1, 2021, conventional cytology was replaced by liquid-based cytology. When making changes to the cervical cancer screening method, a transition period was set until the end of 2021, during which both cytological smear examination and liquid-based cytology could be performed. From July 1, 2022: for women aged 25-29 years - the primary screening examination method is liquid-based cytology, for women aged 30-69 years - the primary screening examination method is high-risk HPV (human papillomavirus) detection.
: Metadata
Result: Taking into account the changes in primary screening methods from July 1, 2022 (in the 25-29 age group - liquid cytology; in the 30-69 age group - high-risk CPV test), the result is classified as “unknown” if the examination method used does not correspond to the method specified in the screening algorithm for the relevant age group or the data is not available due to data system limitations.
Indicator: The proportion of results was calculated from the known examination results, as well as separately for cytology and HPV examination methods.